{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:45:09Z","timestamp":1779317109379,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016YFC1000307"],"award-info":[{"award-number":["2016YFC1000307"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200261"],"award-info":[{"award-number":["82200261"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ymthe.2024.03.028","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T03:28:18Z","timestamp":1711423698000},"page":"1658-1671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Restoring T and B cell generation in X-linked severe combined immunodeficiency mice through hematopoietic stem cells adenine base editing"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0469-2991","authenticated-orcid":false,"given":"Lu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisha","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haikun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongfu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingxu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9249-7496","authenticated-orcid":false,"given":"Xiaohua","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.03.028_bib1","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190607","article-title":"Gene therapy for severe combined immunodeficiencies and beyond","volume":"217","author":"Fischer","year":"2020","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2024.03.028_bib2","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.ymthe.2017.03.018","article-title":"Evolving Gene Therapy in Primary Immunodeficiency","volume":"25","author":"Thrasher","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.03.028_bib3","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jaip.2020.11.055","article-title":"Lifelong Immune Modulation Versus Hematopoietic Cell Therapy for Inborn Errors of Immunity","volume":"9","author":"Cooper","year":"2021","journal-title":"J.\u00a0Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.ymthe.2024.03.028_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad8856","article-title":"Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency","volume":"8","author":"De Ravin","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2024.03.028_bib5","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJMoa012616","article-title":"Sustained correction of X-linked severe combined immunodeficiency by ex\u00a0vivo gene therapy","volume":"346","author":"Hacein-Bey-Abina","year":"2002","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.03.028_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah3480","article-title":"CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease","volume":"9","author":"De Ravin","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2024.03.028_bib7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/ACI.0000000000000483","article-title":"Advances in site-specific gene editing for primary immune deficiencies","volume":"18","author":"Kuo","year":"2018","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.ymthe.2024.03.028_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan0820","article-title":"Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1","volume":"9","author":"Schiroli","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2024.03.028_bib9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.omtn.2022.12.006","article-title":"Multiplex HDR for disease and correction modeling of SCID by CRISPR genome editing in human HSPCs","volume":"31","author":"Iancu","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2024.03.028_bib10","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1038\/s41467-020-17626-2","article-title":"Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich Syndrome","volume":"11","author":"Rai","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.03.028_bib11","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/s41467-019-09614-y","article-title":"Gene correction for SCID-X1 in long-term hematopoietic stem cells","volume":"10","author":"Pavel-Dinu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.03.028_bib12","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41580-019-0131-5","article-title":"The next generation of CRISPR-Cas technologies and applications","volume":"20","author":"Pickar-Oliver","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymthe.2024.03.028_bib13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","article-title":"Identification of preexisting adaptive immunity to Cas9 proteins in humans","volume":"25","author":"Charlesworth","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.03.028_bib14","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41588-021-00838-7","article-title":"Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing","volume":"53","author":"Leibowitz","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2024.03.028_bib15","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/d41587-021-00017-3","article-title":"CRISPR therapies march into clinic, but genotoxicity concerns linger","volume":"39","author":"Sheridan","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.03.028_bib16","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","article-title":"Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors","volume":"38","author":"Anzalone","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.03.028_bib17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41586-021-03191-1","article-title":"The NIH Somatic Cell Genome Editing program","volume":"592","author":"Saha","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.03.028_bib18","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.cell.2023.02.027","article-title":"Human T\u00a0cell generation is restored in CD3delta severe combined immunodeficiency through adenine base editing","volume":"186","author":"McAuley","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2024.03.028_bib19","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1073\/pnas.98.4.1757","article-title":"Distinct role of gp130 activation in promoting self-renewal divisions by mitogenically stimulated murine hematopoietic stem cells","volume":"98","author":"Audet","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.03.028_bib20","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.celrep.2016.09.092","article-title":"Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR\/Cas9","volume":"17","author":"Gundry","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2024.03.028_bib21","doi-asserted-by":"crossref","first-page":"13648","DOI":"10.1073\/pnas.94.25.13648","article-title":"Expansion in\u00a0vitro of adult murine hematopoietic stem cells with transplantable lympho-myeloid reconstituting ability","volume":"94","author":"Miller","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.03.028_bib22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1182\/blood.V83.1.128.128","article-title":"Amplification of Sca-1+ Lin- WGA+ cells in serum-free cultures containing steel factor, interleukin-6, and erythropoietin with maintenance of cells with long-term in\u00a0vivo reconstituting potential","volume":"83","author":"Rebel","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.03.028_bib23","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nbt.4148","article-title":"Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy","volume":"36","author":"Ryu","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.03.028_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15790","article-title":"Improving the DNA specificity and applicability of base editing through protein engineering and protein delivery","volume":"8","author":"Rees","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.03.028_bib25","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/s41587-020-0453-z","article-title":"Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity","volume":"38","author":"Richter","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.03.028_bib26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cels.2016.02.015","article-title":"Plasma Proteome Profiling to Assess Human Health and Disease","volume":"2","author":"Geyer","year":"2016","journal-title":"Cell Syst."},{"key":"10.1016\/j.ymthe.2024.03.028_bib27","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1126\/science.270.5235.475","article-title":"T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years","volume":"270","author":"Blaese","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.03.028_bib28","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1016\/S1525-0016(16)33866-7","article-title":"C-8. Immunological and Metabolic Correction After Lentiviral Vector Gene Therapy for ADA Deficiency","volume":"23","author":"Gaspar","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.03.028_bib29","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1182\/blood-2008-11-191049","article-title":"Efficient construction of producer cell lines for a SIN lentiviral vector for SCID-X1 gene therapy by concatemeric array transfection","volume":"113","author":"Throm","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.03.028_bib30","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/sj.mt.6300393","article-title":"Self-inactivating gammaretroviral vectors for gene therapy of X-linked severe combined immunodeficiency","volume":"16","author":"Thornhill","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.03.028_bib31","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMoa1404588","article-title":"A modified gamma-retrovirus vector for X-linked severe combined immunodeficiency","volume":"371","author":"Hacein-Bey-Abina","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.03.028_bib32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature13420","article-title":"Targeted genome editing in human repopulating haematopoietic stem cells","volume":"510","author":"Genovese","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.03.028_bib33","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1182\/blood-2015-09-672337","article-title":"Long-term multilineage engraftment of autologous genome-edited hematopoietic stem cells in nonhuman primates","volume":"127","author":"Peterson","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.03.028_bib34","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature20134","article-title":"CRISPR\/Cas9 beta-globin gene targeting in human haematopoietic stem cells","volume":"539","author":"Dever","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.03.028_bib35","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41586-021-03609-w","article-title":"Base editing of haematopoietic stem cells rescues sickle cell disease in mice","volume":"595","author":"Newby","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.03.028_bib36","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41467-022-35508-7","article-title":"Therapeutic adenine base editing of human hematopoietic stem cells","volume":"14","author":"Liao","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.03.028_bib37","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41591-020-0790-y","article-title":"Therapeutic base editing of human hematopoietic stem cells","volume":"26","author":"Zeng","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.03.028_bib38","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/s41596-020-00450-9","article-title":"Precision genome editing using cytosine and adenine base editors in mammalian cells","volume":"16","author":"Huang","year":"2021","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2024.03.028_bib39","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.omtn.2022.04.032","article-title":"Engineering of near-PAMless adenine base editor with enhanced editing activity and reduced off-target","volume":"28","author":"Cao","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2024.03.028_bib40","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/s41587-020-0491-6","article-title":"Directed evolution of adenine base editors with increased activity and therapeutic application","volume":"38","author":"Gaudelli","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.03.028_bib41","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1182\/blood-2016-05-715292","article-title":"Erythropoietin modulation is associated with improved homing and engraftment after umbilical cord blood transplantation","volume":"128","author":"Aljitawi","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.03.028_bib42","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1080\/21505594.2016.1208866","article-title":"Immune reconstitution post allogeneic transplant and the impact of immune recovery on the risk of infection","volume":"7","author":"Mehta","year":"2016","journal-title":"Virulence"},{"key":"10.1016\/j.ymthe.2024.03.028_bib43","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1146\/annurev-med-120617-041210","article-title":"Expanding Therapeutic Opportunities for Hematopoietic Stem Cell Transplantation: T Cell Depletion as a Model for the Targeted Allograft","volume":"70","author":"Cho","year":"2019","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ymthe.2024.03.028_bib44","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1182\/blood.2020007362","article-title":"Radiation-induced bystander effects impair transplanted human hematopoietic stem cells via oxidative DNA damage","volume":"137","author":"Hu","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.03.028_bib45","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1089\/hum.2016.103","article-title":"The Role of Conditioning in Hematopoietic Stem-Cell Gene Therapy","volume":"27","author":"Bernardo","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2024.03.028_bib46","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41577-022-00698-0","article-title":"Immunological barriers to haematopoietic stem cell gene therapy","volume":"22","author":"Charlesworth","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2024.03.028_bib47","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/hum.2020.135","article-title":"Conditioning Regimens in Long-Term Pre-Clinical Studies to Support Development of Ex\u00a0Vivo Gene Therapy: Review of Nonproliferative and Proliferative Changes","volume":"32","author":"Chanut","year":"2021","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2024.03.028_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2016.11.011","article-title":"Limiting Thymic Precursor Supply Increases the Risk of Lymphoid Malignancy in Murine X-Linked Severe Combined Immunodeficiency","volume":"6","author":"Ginn","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2024.03.028_bib49","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1021\/acs.jproteome.3c00088","article-title":"Definitive Screening Designs to Optimize Library-Free DIA-MS Identification and Quantification of Neuropeptides","volume":"22","author":"Phetsanthad","year":"2023","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.ymthe.2024.03.028_bib50","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020105896","article-title":"Blood molecular markers associated with COVID-19 immunopathology and multi-organ damage","volume":"39","author":"Chen","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.ymthe.2024.03.028_bib51","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","article-title":"DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput","volume":"17","author":"Demichev","year":"2020","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2024.03.028_bib52","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.cell.2023.02.027","article-title":"Human T\u00a0cell generation is restored in CD3delta severe combined immunodeficiency through adenine base editing","volume":"186","author":"McAuley","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2024.03.028_bib53","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/crispr.2018.0014","article-title":"EditR: A Method to Quantify Base Editing from Sanger Sequencing","volume":"1","author":"Kluesner","year":"2018","journal-title":"CRISPR J."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624001692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624001692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T20:24:04Z","timestamp":1776803044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624001692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1525001624001692"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.03.028","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Restoring T and B cell generation in X-linked severe combined immunodeficiency mice through hematopoietic stem cells adenine base editing","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.03.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s).","name":"copyright","label":"Copyright"}]}}